Tobacco Plants Produce Organ Rejection Saving Anti-Inflammatory Proteins

by Rishika Gupta on  February 27, 2019 at 11:12 PM Research News
RSS Email Print This Page Comment bookmark
Font : A-A+

Organ rejection saving anti-inflammatory proteins can now be produced from tobacco plants, finds a new study. The results of this study are published in the journal of Plant Cell Reports.
 Tobacco Plants Produce Organ Rejection Saving Anti-Inflammatory Proteins
Tobacco Plants Produce Organ Rejection Saving Anti-Inflammatory Proteins

Researchers at Western University and Lawson Health Research Institute are using tobacco plants as 'green bioreactors' to produce an anti-inflammatory protein with powerful therapeutic potential.

The plants are being used to produce large quantities of a human protein called Interleukin 37, or IL-37. The protein is naturally produced in the human kidney in very small quantities and has powerful anti-inflammatory and immune-suppressing properties, providing a potential for treating a number of inflammatory and autoimmune disorders like type 2 diabetes, stroke, dementia and arthritis.

"This protein is a master regulator of inflammation in the body, and has been shown in pre-clinical models to be effective in treating a whole host of diseases," said Dr. Tony Jevnikar, Professor at Western's Schulich School of Medicine & Dentistry and Scientist at Lawson. "The human kidney produces IL-37, but not nearly enough to get us out of an inflammation injury."

And while showing promise in animal models, IL-37's use clinically has been limited because of the inability to produce it in large quantities at a price that is feasible clinically. Currently, it can be made in very small amounts using the bacteria E. coli, but at a very high cost.

That's where the tobacco plants come in.

This work is the first of its kind to demonstrate that this functional human protein can be produced in plant cells. "The plants offer the potential to produce pharmaceuticals in a way that is much more affordable than current methods," said Shengwu Ma, Ph.D., Adjunct Professor in the Department of Biology at Western and Scientist at Lawson. "Tobacco is high-yield, and we can temporarily transform the plant so that we can begin making the protein of interest within two weeks."

The researchers have shown in a recent study published in the journal Plant Cell Reports, that the protein can be extracted and quantified from the plant cells in a way that maintains its function. Now that they've shown they can produce the protein in tobacco, it can be translated to other plants, like potatoes.

Dr. Jevnikar is investigating the effect that IL-37 has for preventing organ injury during transplantation. When an organ is removed for transplantation and then transferred to a recipient, inflammation occurs when the blood flow is restored to the organ. He and his team believe IL-37 provides a way to prevent that injury.

"I hope that this work will impact a change in how people view plants and hopefully this approach will be a way to provide treatments to patients that are effective and affordable," Dr. Jevnikar said.

Source: Eurekalert

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions
Advertisement

Recommended Reading

More News on:

Tongue Abnormalities Health Hazards of Smoking Smoking And Cancer Smoking And Tobacco Magical Millets for Your Health Baby Food - Basics Nutrition IQ Top Ten Foods That Trigger Inflammation 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive